Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen

Novartis

Status: Terminated

Conditions: Rabies

Treatments: Other: No vaccine administered; subjects only have blood sampling for immunogenicity

Study type: Observational

Funder types: Industry

Identifiers

NCT01067079

M49P8E1

Details and patient eligibility

About

This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules

Enrollment: 200 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male and Female subjects who received complete vaccine series in accordance to the designated vaccination schedule in the previous M49P8 study

Exclusion criteria

• Any disease condition, that in the opinion of investigator may interfere with subjects ability to participate in the study.
• Receipt of additional doses of rabies vaccine after completion of initial vaccine series.
• For additional entry criteria please refer to protocol.

Trial design

200 participants in 1 patient group

Arm 1

Treatment:

Other: No vaccine administered; subjects only have blood sampling for immunogenicity